Advertisement
Research Article

Soluble Rhesus Lymphocryptovirus gp350 Protects against Infection and Reduces Viral Loads in Animals that Become Infected with Virus after Challenge

  • Junji Sashihara,

    Affiliation: Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    Current address: Department of Pediatrics, Kansai Rousai Hospital, Hyogo, Japan.

    X
  • Yo Hoshino,

    Affiliation: Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    Current address: Astellas Pharma Inc., Tokyo, Japan.

    X
  • J. Jason Bowman,

    Affiliation: Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Tammy Krogmann,

    Affiliation: Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Peter D. Burbelo,

    Affiliation: Neurobiology and Pain Therapeutics Section, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • V. McNeil Coffield,

    Affiliation: AlphaVax, Inc., Research Triangle Park, North Carolina, United States of America

    Current address: Department of Biology, High Point University, High Point, North Carolina, United States of America.

    X
  • Kurt Kamrud,

    Affiliation: AlphaVax, Inc., Research Triangle Park, North Carolina, United States of America

    Current address: Harrisvaccines, Inc. Ames, Iowa, United States of America.

    X
  • Jeffrey I. Cohen mail

    jcohen@niaid.nih.gov

    Affiliation: Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Published: October 20, 2011
  • DOI: 10.1371/journal.ppat.1002308

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.